Walgreens Boots Alliance Inc (WBA)
34.60
-0.03
(-0.09%)
USD |
NASDAQ |
Mar 31, 16:00
34.79
+0.19
(+0.55%)
After-Hours: 17:38
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 29.85B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -23.37% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.2244 |
| Price to Book Value | 1.409 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.48 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.6155 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 58.77% |
News
Headline
Wire
Time (ET)
MT Newswires
03/30 10:09
MT Newswires
03/29 12:25
MT Newswires
03/29 08:48
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 06/30/2023* | -- | Results | Q3 2023 | -- | 1.11 | -- | |
| 06/30/2023* | 08:30 EST | Earnings Call | Q3 2023 | -- | -- | -- | |
| 03/28/2023 | -- | Results | Q2 2023 | -- | 1.11 | -- | |
| 03/28/2023 | 08:30 EST | Earnings Call | Q2 2023 | -- | -- | -- | |
| 01/05/2023 | -- | Results | Q1 2023 | 1.16 | 1.14 | 1.50% | |
| 01/05/2023 | 08:30 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 10/13/2022 | -- | Results | Q4 2022 | 0.80 | 0.77 | 3.75% | |
| 10/13/2022 | 08:30 EST | Earnings Call | Q4 2022 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
| Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S. With over 8,500 locations, nearly three-quarter of Americans live within five miles of a Walgreens location. Roughly two-thirds of revenue is generated from prescription drug sales, and Walgreens makes up 20% of total prescription revenues in the U.S. Walgreens also generates sales from retail product sales (general wellness consumables and own branded merchandise), European drug wholesale business, and healthcare business. With more locations incorporating additional services like Health Corners and Village Medical in store, Walgreens creates an omni-channel experience for patients and positions itself as a one-stop healthcare provider. |
| URL | https://www.walgreensbootsalliance.com |
| Investor Relations URL | https://investor.walgreensbootsalliance.com |
| HQ State/Province | Illinois |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | Jun. 30, 2023 (est.) |
| Last Earnings Release | Mar. 28, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 15, 2023 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 1.918 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 3.998 |
| Yield to Sector | 2.666 |
| Yield to Industry | 1.642 |
| Last Dividend Amt. | 0.48 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Feb. 15, 2023 |
| Yield (TTM) | 5.54% |
| Forward Yield | 5.54% |
| Payout Ratio | -52.64% |
| Cash Payout Ratio | 168.5% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 30, 2023.
Fundamentals
| Revenue (TTM) | 133.29B |
| Total Expenses (TTM) | 140.73B |
| Net Income (TTM) | -3.144B |
| Total Assets (Quarterly) | 100.48B |
| Total Liabilities (Quarterly) | 70.88B |
| Shareholders Equity (Quarterly) | 21.19B |
| Cash from Operations (TTM) | 2.954B |
| Cash from Investing (TTM) | -2.466B |
| Cash from Financing (TTM) | -502.00M |
Ratings
Profile
| Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S. With over 8,500 locations, nearly three-quarter of Americans live within five miles of a Walgreens location. Roughly two-thirds of revenue is generated from prescription drug sales, and Walgreens makes up 20% of total prescription revenues in the U.S. Walgreens also generates sales from retail product sales (general wellness consumables and own branded merchandise), European drug wholesale business, and healthcare business. With more locations incorporating additional services like Health Corners and Village Medical in store, Walgreens creates an omni-channel experience for patients and positions itself as a one-stop healthcare provider. |
| URL | https://www.walgreensbootsalliance.com |
| Investor Relations URL | https://investor.walgreensbootsalliance.com |
| HQ State/Province | Illinois |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | Jun. 30, 2023 (est.) |
| Last Earnings Release | Mar. 28, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 15, 2023 |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| SPHD | 84.02M USD | 2.39% |
| RPV | 62.64M USD | 2.09% |
| SDY | 405.11M USD | 1.80% |
| OFALX | 9.859M USD | 1.74% |
| DVY | 349.92M USD | 1.68% |
| PKAAX | 14.61M USD | 1.43% |
| FLPKX | 334.47M USD | 1.20% |
| FLKSX | 36.11M USD | 1.20% |
| VCSAX | 88.98M USD | 1.14% |
| VDC | 88.98M USD | 1.14% |
| XLP | 189.43M USD | 1.12% |
| QCENX | 10.02M USD | 1.10% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| WBA Tweets |